MnM_logo_TM_JPG.JPG
Pharmacogenomics Market is Expected to Reach $5.8 Billion | MarketsandMarkets™
04 mars 2024 07h30 HE | MarketsandMarkets Research Pvt. Ltd.
Chicago, March 04, 2024 (GLOBE NEWSWIRE) -- Pharmacogenomics market in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR...
mrf.jpg
Pharmacogenomics Market Size Worth USD 6670.3 Million by 2030 at 8.52% CAGR – Report by Market Research Future (MRFR)
09 juin 2023 14h29 HE | Market Research Future
New York, USA, June 09, 2023 (GLOBE NEWSWIRE) -- Pharmacogenomics Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Pharmacogenomics Market...
logo-alt.png
Pharmacogenomics Market is estimated to be US$ 33.10 million by 2030 with a CAGR of 4.50% during the forecast period - By PMI
14 mars 2023 08h35 HE | PMI
Covina, March 14, 2023 (GLOBE NEWSWIRE) -- Pharmacogenomics Market accounted for US$ 6753.66 million in 2020 and is estimated to be US$ 15796.9 million by 2030 and is anticipated to register a CAGR...
logo.png
Pharmacogenomics Market Size to Surpass Around USD 36.7 Bn by 2030
26 août 2022 11h02 HE | Precedence Research
New York, Aug. 26, 2022 (GLOBE NEWSWIRE) -- The global pharmacogenomics market size will reach at USD 16.76 billion in 2022. The rapid increase of the pharmacogenomics technologies and advanced drug...
AMR Logo.png
Pharmacogenomics Market Size to Hit $10.2 Billion, by 2025 at 8.6% CAGR
27 oct. 2020 09h54 HE | Allied Market Research
PORTLAND, Ore., Oct. 27, 2020 (GLOBE NEWSWIRE) -- The global Pharmacogenomics Market garnered $5.3 billion in 2017, and is expected to reach $10.2 billion by 2025, registering a CAGR of 8.6% from...
logo 600X600.png
Global Pharmacogenomics Market to Surpass US$ 14.6 Billion by 2025
23 nov. 2017 07h00 HE | Coherent Market Insights
SEATTLE, Nov. 23, 2017 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global pharmacogenomics market was valued at US$ 7,623.9 Million in 2016 and is projected to witness a CAGR of...